Patriot Financial Group Insurance Agency 13F: Adds $861K to MDT Stake

Patriot Financial Group Insurance Agency recently increased its stake in Medtronic plc (NYSE:MDT), according to its latest Form 13F filing with the SEC. The firm added 9,976 shares, boosting its holdings by nearly 25% to a total of 49,893 shares. This investment is valued at approximately $4.31 million as of the reporting period.

What Changed in Patriot Financial Group's Medtronic Position

Patriot Financial Group's latest filing reflects a significant increase in its position in Medtronic. The firm previously held 39,917 shares and has now increased its stake by 9,976 shares, marking a 24.99% increase. The total value of this position stands at about $4.31 million.

Medtronic plc Stock Down 1.0%

Shares of Medtronic have been trading within a range of $73.31 to $106.33 over the past 52 weeks. As of the latest data, Medtronic has a market capitalization of $117.36 billion and a P/E ratio of 22.6, suggesting investors are willing to pay $22.60 for every dollar of earnings. The company's stock has a beta of 0.574, indicating it is less volatile than the overall market. Medtronic's 50-day moving average is $88.86, while its 200-day moving average is $89.21. The firm's current ratio is 2.067, and it has a quick ratio of 1.286, with a debt-to-equity ratio of 55.365.

Recent Earnings

Medtronic reported revenues of approximately $37.54 billion, with a revenue growth rate of 13.7%. The company's net margin stands at 13.93%, and its return on equity is 10.65%. Medtronic's earnings per share (EPS) is $4.06. The next earnings report is expected on November 17, 2026.

Dividend

Medtronic offers an annual dividend of $2.88 per share, which yields 3.13% based on recent prices. The company's dividend payout ratio is 70.2%, indicating a substantial portion of earnings is returned to shareholders. The ex-dividend date was not provided.

About Medtronic

Medtronic plc is a global leader in medical technology, headquartered in Galway, Ireland. The company develops, manufactures, and sells medical devices and therapies to healthcare systems, physicians, and patients worldwide. It operates through three main segments: Cardiovascular, Neuroscience, and Medical Surgical. Medtronic is known for its innovative products in cardiac, vascular, and surgical fields, serving a wide range of medical professionals and patients.

Bottom Line

Patriot Financial Group's decision to increase its stake in Medtronic reflects a strategic move to strengthen its investment in the healthcare sector. Investors often watch 13F filings like these to gauge institutional confidence in a company's prospects. It's important to remember that these filings are backward-looking and may not represent the investor's current position.